NHLD - National Holdings Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
3.35
0.00 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close3.35
Open3.38
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.34 - 3.43
52 Week Range2.08 - 6.26
Volume10,234
Avg. Volume47,614
Market Cap41.667M
Beta0.25
PE Ratio (TTM)N/A
EPS (TTM)-0.06
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1996-05-02
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire10 hours ago

    Marrone Bio Innovations Announces Exercise of Over-Allotment Option in Public Offering of Common Stock

    DAVIS, Calif., April 26, 2018-- Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, ...

  • GlobeNewswire7 days ago

    Marrone Bio Innovations Announces Closing of $12 Million Public Offering of Common Stock

    Marrone Bio Innovations, Inc. (MBII) (MBI or the “Company”), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, announced today the closing of its previously announced underwritten public offering of registered shares of its common stock for gross proceeds of approximately $12.0 million.  A total of 7,275,000 shares were sold in the offering at a price to the public of $1.65 per share.  The net proceeds are expected to be approximately $11.0 million, after deducting estimated underwriting discounts, commissions, and estimated offering expenses payable by the Company. In connection with the offering, the Company has also granted the underwriter a 45-day option to purchase up to an additional 1,091,250 shares of common stock to cover over-allotments, if any, which if exercised in full would increase the gross proceeds of the offering to $13.8 million, and anticipated net proceeds to $12.7 million.  The Company intends to use the net proceeds from the offering primarily for general corporate purposes.

  • GlobeNewswire9 days ago

    Marrone Bio Innovations, Inc. Announces Pricing of Its Common Stock Offering

    Marrone Bio Innovations, Inc. (MBII) (or "the Company"), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced the pricing of its previously announced underwritten public offering. The Company is offering 7,275,000 registered shares of its common stock, par value $0.00001 per share, at a price to the public of $1.65 per share, resulting in gross proceeds of approximately $12 million. In connection with the offering, the Company has also granted the underwriter a 45-day option to purchase up to an additional 1,091,250 shares of common stock offered in the public offering to cover over-allotments, if any.

  • GlobeNewswire9 days ago

    Marrone Bio Innovations, Inc. Announces Proposed Public Offering of Common Stock

    DAVIS, Calif., April 17, 2018-- Marrone Bio Innovations, Inc. or, a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment ...

  • GlobeNewswire11 days ago

    Stemline Therapeutics Expands Board of Directors; Further Enhances Commercial Expertise with Appointment of Darren Cline

    NEW YORK, April 16, 2018-- Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel oncology therapeutics, today announced expansion of its Board of Directors to include ...

  • PR Newswire24 days ago

    Biopharm Startup TFF Pharmaceuticals Raises $14M for Breakthrough Dry Powder Inhalation Platform

    The Series A financing will support further development of the Company's pipeline of transformative dry powder drugs for pulmonary diseases and conditions. AUSTIN, Texas, April 3, 2018 /PRNewswire/ -- TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products for the treatment of lung diseases and conditions, announced it has closed an offering of Series A preferred stock for gross proceeds of $14 million. The offering will be used to accelerate development of the Company's pipeline of advanced performance dry powder drugs for the treatment of pulmonary diseases and conditions such as lung transplant, severe asthma, COPD, and pulmonary infections.

  • GlobeNewswirelast month

    Gladstone Land Corporation Announces Pricing of Common Stock Offering

    MCLEAN, Va., March 27, 2018-- Gladstone Land Corporation today announced that it has priced its public offering of 1,100,000 shares of its common stock at a price to the public of $12.15 per share. The ...

  • PR Newswirelast month

    VolitionRx Announces Closing of $8.4 Million Public Offering of Common Stock

    ISNES, Belgium, March 13, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN:  VNRX) ("Volition"), a multi-national life sciences company focused on developing simple, easy to use, cost effective blood tests designed to help diagnose a range of cancers, announced today the closing of its previously announced underwritten public offering of 3,500,000 shares of common stock at a public offering price of $2.40 per share for gross proceeds of $8.4 million, before deducting underwriting discounts, commissions and estimated offering expenses payable by Volition.  All of the shares of common stock sold in the offering were offered by Volition. Volition intends to use the net proceeds of the offering for continued product development, clinical studies, product commercialization, working capital, and other general corporate purposes.

  • PR Newswire2 months ago

    VolitionRx Announces Pricing of $8.4 Million Public Offering of Common Stock

    ISNES, Belgium , March 9, 2018 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national life sciences company focused on developing simple, easy to use, cost effective ...

  • PR Newswire2 months ago

    VolitionRx Announces Proposed Underwritten Public Offering of Common Stock

    Oppenheimer & Co. Inc. is acting as the sole book-running manager for the proposed offering.  National Securities Corporation, a wholly owned subsidiary of National Holdings Corporation (NHLD), is acting as a co-manager in connection with the offering. Volition intends to use the net proceeds of the offering for continued product development, clinical studies, product commercialization, working capital, and other general corporate purposes.

  • GlobeNewswire2 months ago

    Checkpoint Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock

    NEW YORK, March 08, 2018-- Checkpoint Therapeutics, Inc., a Fortress Biotech company, today announced the pricing of its previously announced underwritten public offering. Checkpoint is offering 4,600,000 ...

  • GlobeNewswire2 months ago

    Checkpoint Therapeutics, Inc. Announces Proposed Public Offering of Common Stock

    NEW YORK, March 07, 2018-- Checkpoint Therapeutics, Inc., a Fortress Biotech company, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in ...

  • PR Newswire2 months ago

    ClearSign Combustion Corporation Closes $12.94 M Public Offering of Common Stock

    SEATTLE, Feb. 27, 2018 /PRNewswire/ -- ClearSign Combustion Corporation (CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion technologies that reduce emissions and improve efficiency, today announced the closing of its previously announced underwritten public offering of 5,000,000 shares of common stock at a price of $2.25 per share. In addition, the underwriter exercised the over-allotment option to purchase 750,000 additional shares of common stock at the public offering price. All of the common stock was offered by the Company.

  • PR Newswire2 months ago

    ClearSign Combustion Corporation Announces Pricing Of Public Offering Of Common Stock

    SEATTLE, Feb. 23, 2018 /PRNewswire/ -- ClearSign Combustion Corporation (CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion technologies that reduce emissions and improve efficiency, today announced the pricing of its previously announced underwritten public offering. ClearSign is offering 5,000,000 shares of its common stock, par value $0.0001 per share, at a price to the public of $2.25 per share. In connection with the offering, ClearSign has also granted the underwriter a 45-day option to purchase up to an additional 750,000 shares of common stock offered in the public offering to cover over-allotments, if any.

  • PR Newswire2 months ago

    ClearSign Combustion Corporation Announces Proposed Public Offering of Common Stock

    SEATTLE, Feb. 22, 2018 /PRNewswire/ -- ClearSign Combustion Corporation (CLIR) ("ClearSign" or the "Company"), an emerging leader in industrial combustion technologies that reduce emissions and improve efficiency, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering. ClearSign expects to grant the underwriter a 45-day option to purchase up to an additional 15 percent of the shares of common stock offered in the public offering to cover over-allotments, if any. All of the common stock is being offered by the Company.  ClearSign intends to use the net proceeds from the offering primarily for research and development, sales and marketing, business development, working capital and general corporate purposes.

  • GlobeNewswire2 months ago

    National Holdings Corporation Reports Financial Results for the Fiscal 2018 First Quarter

    NEW YORK, Feb. 14, 2018-- National Holdings Corporation, a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, ...

  • GlobeNewswire3 months ago

    Marrone Bio Innovations, Inc. Announces Closing of Private Placement and Debt Refinancing Transactions

    DAVIS, Calif., Feb. 06, 2018-- Marrone Bio Innovations, Inc., a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, ...

  • GlobeNewswire3 months ago

    National Securities Corporation Successfully Arranges $75,000,000 Private Placement and Debt Refinancing for Marrone Bio Innovations, Inc.

    NEW YORK, Feb. 06, 2018-- National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc., a leading full service independent brokerage, investment banking and asset management firm, ...

  • GlobeNewswire3 months ago

    Marrone Bio Innovations, Inc. Announces Stockholder Approval of Private Placement and Debt Refinance Transactions

    Appoints Two New Board Members; Bob Woods as Chairman and Yogesh Mago. Transactions Expected to Close in Early February. DAVIS, Calif., Feb. 01, 2018-- Marrone Bio Innovations, Inc., a leading provider ...

  • PR Newswire3 months ago

    SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating National Holdings Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors

    NEW YORK , Jan. 18, 2018 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty ...

  • Best-In-Class NYSE Undervalued Stocks
    Simply Wall St.4 months ago

    Best-In-Class NYSE Undervalued Stocks

    Qudian and National Holdings may be trading at prices below their likely values. This suggests that these stocks are undervalued, meaning we can benefit when the stock price moves toRead More...

  • Capital Cube4 months ago

    ETFs with exposure to National Holdings Corp. : December 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to National Holdings Corp. Here are 5 ETFs with the largest exposure to NHLD-US. Comparing the performance and risk of National Holdings Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)